Publication Details
Abstract
Coronavirus disease-2019 (COVID-19) is a new epidemic infectious disease characterized by relatively high contagiousness and the likelihood of developing serious complications in the form of acute respiratory distresssyndrome, acute respiratory and multiple organ failure. The pathogenesis of the new coronavirus infection is not sufficiently studied, it is spreading around the world for the second year. The virus is neurotropic, that is, when it enters the nervous system through olfactory receptors in the upper nasal concha, it can directly damage brain structures such as the limbic system and hypothalamus [6]. Doctors in many countries note that among the various complications after a previous illness, a significant part of patients may also develop cognitive disorders: memory, attention, concentration, or speed of thought processes [2, 4]. According to a recent non-selective survey of the US population conducted by According to the American Psychiatric Association, almost half of the respondents experience a serious level of anxiety and 40% are afraid that they or their loved ones may become seriously ill with COVID-19 and die [1, 5]. The prevalence of moderate to severe symptoms in COVID-19 тяжелыхwas as follows: anxiety-12-20%, depression-15-25%, insomnia-8% , and traumatic stress-35-49% [3]. Based on these data, emotional-volitional disorders in the post-covid period are of great interest and require the development of treatment tactics.